Create

a New World

We strive to be a global biopharma leader whose mission is to develop innovative,

life-changing medicine.

Innovations to improve

Quality of Life

We strive to be a global biopharma leader whose mission is to develop innovative,

life-changing medicine.

Accelerating Drug

Developments

We strive to be a global biopharma leader whose mission is to develop innovative,

life-changing medicine.

New Paradigms to

Solve Unmet

Medical Needs

We strive to be a global biopharma leader whose mission is to develop innovative,

life-changing medicine.

Working Together

for a Healthier

Future

We strive to be a global biopharma leader whose mission is to develop innovative,

life-changing medicine.

Pipeline

Focusing on Diseases

of High Unmet Medical Needs

Our research team is focused on the discovery of novel therapies for diseases with
high unmet medical needs - leveraging our platform technology and core competencies.

Acelex
Reducing pain and inflammation

while improving physical function
in osteoarthritis patients

VIEW MORE

TECHNOLOGY
Track Record
  • 1st in Korea

    First research team from Korea to publish a Nature cover story

  • 1.5 Trillion Won

    Experience with exporting / licensing deals - Combined total value of recent deals for Acelex (966.6 Billion Won) and CG-806 (4,874 Billion Won) is ~1.5 Trillion Won

  • 95%

    Research driven workforce - 95% of CrystalGenomics' workforce consists of life science professionals with Masters and Ph.D.s

  • No.1

    Next-gen Biopharma leader - Moving into the future to become a biopharmaceutical R&D technology leader.